Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?

Kidney International

Volumn 52, Issue 6, 1997, Pages 1439-1457

  Schena, Francesco Paolo ^a   Gesualdo, Loreto ^a   Grandaliano, Giuseppe ^a   Montinaro, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cytokines; Glomerular cells; Glomerulonephrides; Growth factors; Monocytes macrophages; Progression of renal disease; T cells

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR;

DIET THERAPY; GENE THERAPY; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY INJURY; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 0031466831     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.475     Document Type: Article

References (249)

1. HELD PJ, PORT FK, WEBB RL, WOLFE RA, BLOEMBERGEN WE, TURENNE MN, HIRT R, YOUNG EW, OJO AD, STRAWDERMAN RL, WOODS JD, TEDESCHI PJ, CARROLL, CE, HULBERT-SCHEARON T, ZHANG Q, LEVINE GN, HATCHER D, JONES CA, GEER JW, AGODOA LYC: Excerpts from the USRDS 1996 annual data report. II. Incidence and causes of ESRD. Am J Kidney Dis 28(Suppl 2):S34-S47, 1996
2. VALDERRABANO F, JONES EHP, MALLICK NP: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 10(Suppl 5):4-9, 1995
3. WOO KT: The Singapore Renal Registry: An overview. Singapore Med J 34:157-163, 1993
4. SHINZATO T, NAKAI S, AKIBA T, YAMAZAKI C, SASAKI R, KITAOKA T, KUBO K, SHINODA T, KUROKAWA K, MARUMO F, SATO T, MAEDA K: Current status of renal replacement therapy in Japan: Results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 11:2143-2150, 1996
5. LI L: End-stage renal disease in China. Kidney Int 49:287-301, 1996
6. DISNEY AP: Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zeland: Report on dialysis and renal transplantation treatment from the Australia and New Zeland Dialysis and Transplant Registry. Am J Kidney Dis 25:165-175, 1995
7. GLASSOCK RJ, ADLER SG, WARD HJ: Primary glomerular diseases, in The Kidney, edited by BRENNER B, Philadelphia, WB Saunders, 1991, pp 1182-1279
8. BOHLE A, WEHRMANN M, MACKENSEN-HAEN S, GISE HV, MICKELER E, XIAO TC, MULLER C, MULLER GA: Pathogenesis of chronic renal failure in primary glomerulonephritis. Nephrol Dial Transplant S3:4-12, 1994
9. SCHENA FP, GESUALDO L: Renal biopsy-beyond histology and immunofluorescence. Nephrol Dial Tranplant 9:1541-1544, 1994
10. NOLASCO FE, CAMERON JS, HARTHLEY B, COELHO A, HILDRETH G, REUBEN R: Intraglomerular T cell and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 32:1160-1166, 1987
11. VAN GOOR H, DING G, KEES-FOLTS D, GROND J, SCHREINER GF, DIAMOND JR: Macrophages and renal disease. Lab Invest 71:456-464, 1994
12. SCHENA FP, MONTINARO V, GESUALDO L: Glomerular mesangial and epithelial cells, in Immunopharmacology of the Renal System, edited by TETTA C, London, Academic Press, 1993, pp 49-86
13. GRUNEWALD J, WIGZELL H: T-cell expansions in healthy individuals. The Immunologist 4:99-103, 1996
14. MOSMANN TR, SAD S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
15. MOSMANN TR, SCHUMACHER JH, STREET NF, BUDD R, O'GARRA A, FONG TAT, BOND MW, MOORE KWM, SHER A, FIORENTINO DF: Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 123:209, 1991
16. ROMAGNANI S: Development of Th 1 or Th 2-dominated immune responses: What about the polarizing signals? Int J Clin Lab Res 26:83-98, 1996
17. WARDLE EN: Neutralizing inflammatory cytokines in nephritis. Nephron 69:223-227, 1995
18. HUANG XR, HOLDSWORTH SR, TIPPING PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
19. GOLDMAN M, DRUET P, GLEICHMANN E: Th2 cells in systemic autoimmunity: Insights from allogenic diseases and chemically-induced autoimmunity. Immunol Today 12:223-227, 1991
20. FERRARIO F, CASTIGLIONE A, COLASANTI G, BARBIANO DI BELGIOIOSO G, BERTOLI S, D'AMICO G: The detection of monocytes in human glomerulonephritis. Kidney Int 28:513-519, 1985
21. NATHAN CF: Secretory products of macrophages. J Clin Invest 79:319-326, 1987
22. MENÈ P, SIMONSON MS, DUNN M: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
23. ZOJA C, WANG JM, BETTONI S, SIRONI M, RENZI D, CHIAFFARINO F, ABBOUD HE, VAN DAMME J, MANTOVANI A, REMUZZI G, RAMBALDI A: Interleukin-1β and tumor necrosis factor-α induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factor, and interleukin-6 in human mesangial cells. Am J Pathol 138:991-1003, 1991
24. ABBOUD HE: Growth factors in glomerulonephritis. Kidney Int 43:252-267, 1993
25. TAGA T, KISHIMOTO T: Cytokine receptors and signal transduction. FASEB J 7:3387-3396, 1992
26. MIZEL SB: The interleukins. FASEB J 7:2379-2388, 1989
27. KAPLAN D: Autocrine secretion and the physiological concentration of cytokines. Immunol Today 17:303-304, 1996
28. CARDING SR, HAVDAY AC, BOTTOMLY K: Cytokines in T-cell development. Immunol Today 12:239-245, 1991
29. HERRMANN F, GEBAUER G, LINDEMANN A, BRACH M, MERTELSMANN R: Interleukin-2 and interferon-gamma recruit different subjets of human peripheral blood monocytes to secrete interleukin-1 beta and tumor necrosis factor-alpha. Clin Exp Immunol 77:97-100, 1989
30. DRAPIER JC, WIETZERBIN J: IFN-γ reduces specific binding of tumor necrosis factor on murine macrophages. J Immunol 146:1198-1204, 1991
31. GRANDALIANO G, VALENTE AJ, ROZEK MM, ABBOUD HE: Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells. J Lab Clin Med 123:282-289, 1994
32. SCHMOUDER RL, STRIETER RM, KUNKEL SL: Interferon γ regulation of human cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 44:43-49, 1993
33. THORNHILL MH, KYAN-AUNG U, HASKARD DO: IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol 144:3060-3065, 1990
34. MILLER CL, HOOTON JWL, GILLIS S, PAETKAU V: IL-4 potentiates the IL-2-dependent proliferation of mouse cytoloxic T cells. J Immunol 144:1331-1337, 1990
35. THORNHILL MH, HASKARD DO: IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J Immunol 145:865-872, 1990
36. TADMORI W, LEE HK, CLARK SC, CHOI YS: Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors. J Immunol 142:826-832, 1989
37. STANDIFORD TJ, STRIETER RM, CHENSUE SW, WESTWICK J, KASAHARA K, KUNKEL SL: IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 145:1435-1439, 1990
38. PAUL WE: Interleukin 4: A prototypic immunoregulatory lymphokine. Blood 77:1859, 1991
39. MITCHELL LC, DAVIS LS, LIPSKY PE: Promotion of human T lymphocyte proliferation by IL-4. J Immunol 142:1548-1557, 1989
40. DONNELLY RP, CROFFORD LJ, FREEMAN SL, BURAS J, REMMERS E, WILDER RL, FENTON MJ: Tissue-specific regulation of IL-6 production by IL-4. J Immunol 151:5603-5612, 1993
41. TE VELDE AA, HUIJBENS RJF, DE VRIES JE, FIGDOR CG: IL-4 decreases FcγR membrane expression and FcγR-mediated cytotoxic activity of human monocytes. J Immunol 144:3046-3051, 1990
42. HOWARD M, O'GARRA A: Biological properties of interleukin 10. Immunol Today 13:198-200, 1992
43. DEL PRETE G, DE CARLI M, ALMERIGOGNA F, GIUDIZI MG, BIAGIOTTI R, ROMAGNANI S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-360, 1993
44. ZURAWSKI G, DE VRIES JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19-26, 1994
45. EGIDO J, GOMEZ-CHIARRI M, OTRIZ A, BUSTOS C, ALONSO J, GOMEZ GUERRERO C, GOMEZ GARRE D, LOPEZ-ARMADA MJ, PLAZA J, GONZALES E: The role of tumor necrosis factor in the pathogenesis of glomerular disease. Kidney Int 42(Suppl 39):S59-S64, 1993
46. FOUQUERAY B, PHILIPPE C, HERBELIN A, PEREZ J, ARDAILLOU R, BAUD L: Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol 3:1783-1791, 1993
47. PAI R, HA H, KIRSCHENBAUM MA, KAMANNA V: Role of tumor necrosis factor α on mesangial cell MCP-1 expression and monocyte migration: Mechanisms mediated by signal transduction. J Am Soc Nephrol 7:914-923, 1996
48. ORTIZ A, GONZALES-CUADRADO S, BUSTOS C, ALONSO J, GOMEZ-GUERRERO C, LOPEZ-ARMANDA MJ, GONZALEZ ARANA E, PLAZA JJ, EGIDO J: Tumor necrosis factor as a mediator of glomerular damage. J Nephrol 8:27-34, 1995
49. VAN KOOTEN C, RENSINK I, PASCUAL-SALCEDO D, VAN OERS R, AARDEN L: Monokine production by human T cells; IL-1α production restricted to memory T cells. J Immunol 146:2654-2658, 1991
50. MARUCHA PT, ZEFF RA, KREUTZER DL: Cytokine-induced IL-1β gene expression in the human polymorphonuclear leulocyte: Transcription and post-transcriptional regulation by tumor necrosis factor and IL-1. J Immunol 147:2603-2608, 1991
51. ABBOTT F, TAM FWK, RYAN JJ, REES AJ: Human mesangial cells synthesize interleukin 1alpha but not interleukin 1beta, interleukin 1 receptor antagonist, or tumor necrosis factor. Nephrol Dial Transplant 10:997-1001, 1992
52. TIPPING PG, LOWE MG, HOLDSWORTH SR: Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int 39:103-110, 1991
53. LONNEMANN G, SHAPIRO L, ENGLER-BLUM G, MÜLLER GA, KOCH KM, DINARELLO CA: Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblast. Kidney Int 47:837-844, 1995
54. LONNEMANN G, ENGLER-BLUM G, MÜLLER GA, KOCH KM, DINARELLO CA: Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int 47:845-854, 1995
55. AIELLO FB, LONGO DL, OVERTON R, TAKACS L, DURUM SK: A role for cytokines in antigen presentation: IL-1 and IL-4 induce accessory functions of antigen-presenting cells. J Immunol 144:2572-2581, 1990
56. COLEMANN D, RUEF C: IL-6: An autocrine regulator of mesangial cell growth. Kidney Int 41:604-608, 1992
57. SMYTH MJ, ORTALDO JR, BERE W, YAGITA H, OKUMURA K, YOUNG HA: IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 145:1159-1166, 1990
58. HORII Y, MURAGUCHI A, IWANO M, MATSUDA T, HIRAYAMA T, YAMADA H, FUSII T, DOHI K, ISHIKAWA H, OHMOTO Y, YOSHIZAKI K, HIRANO T, KISHIMOTO T: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949-395, 1989
59. SANCEAU J, WIJDENES J, REVEL M, WIETZERBIN J: IL-6 and IL-6 recptor modulation by IFN-γ and tumor necrosis factor-α in human monocytic cell line (THP-1). J Immunol 147:2630-2637, 1991
60. OPPENHEIM JJ, ZACHARIAE COC, MULAIDA N, MATSUSHIMA K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648, 1991
61. MILLER MD, KRANGEL MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. CRC Crit Rev Immunol 12:17-46, 1992
62. CLORE GM, GRONENBORN AM: Three-dimensional structures of a and β chemokines. FASEB J 9:57-62, 1995
63. ROVIN BH, YOSHIMURA T, TAN L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153, 1992
64. BROWN Z, STRIETER RM, CHENSUE SW, CESKA M, LINDLEY I, NEILD GH, KUNKEL SL, WESTWICK J: Cytokine-activated human mesangial cells generate the neutrophil chemoattract, interleukin-8. Kidney Int 40:86-90, 1991
65. FOUQUERAY B, GRANDALIANO G, WENZEL UO, BHANDARI B, WOODRUFF K, VALENTE AJ, ABBOUD HE: Cytokines and thrombin regulate MCP-1 gene expression in bovine glomerular endothelial cells. (abstract) J Am Soc Nephrol 5:747, 1994
66. SATRIANO J, SCHLONDORFF D: Induction of RANTES and ICAM-1 in mesangial cells (MC) involves reactive oxygen intermediates and is attenuated by forskolin. (abstract) J Am Soc Nephrol 5:729, 1994
67. SATRIANO JA, SCHULDINER M, HORA K, XING Y, SHAN Z, SCHLONDORFF D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin γ. J Clin Invest 92:1564-1571, 1993
68. HORA K, SATRIANO JA, SANTIAGO A, MORI T, STANLEY ER, SHAN Z, SCHONDORFF D: Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide-1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89:1745-1749, 1992
69. GRANDALIANO G, VALENTE AJ, ABBOUD HE: A novel biologic activity of thrombin: Stimulation of monocyte chemotactic protein production. J Exp Med 179:1737-1741, 1994
70. ROVIN BH, RAN LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
71. GRANDE JP, JONES ML, SWENSON CL, KILLEN PD, WARREN JS: Lipopolysaccaride induces monocyte chemoattractant protein production by rat mesangial cells. J Lab Clin Med 124:112-117, 1994
72. JOHNSON RJ, FLOEGE J, COUSER WG, ALPERS CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4:119-128, 1993
73. SILVER BJ, JAFFER FE, ABBOUD HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci USA 86:1056-1060, 1989
74. JAFFER FE, KNAUSS TC, POPTIC E, ABBOUD HE: Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int 38:1193-1198, 1990
75. SHULTZ PJ, KNAUSS TC, MENÉ P, ABBOUD HE: Mitogenic signals for thrombin in mesangial cells: Regulation of phospholipase C and PDGF cells: Regulation of phospholipase C and PDGF genes. Am J Physiol 257:F366-F374, 1989
76. ROBERTS WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
77. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER GE: Transforming growth factor-β: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
78. SHULL MM, ORMSBY I, KIER AB, PAWLOSKY S, DIEBOLD RJ, YIN M, ALLEN R, SIDMAN C, PROETZEL G, CALVIN D, ANNUNZIATA N, DOETSCHMAN T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
79. FLOEGE J, ENG E, LINDNER V, ALPERS CE, YOUNG BA, REIDY MA, JOHNSON RJ: Rat glomerular mesangial cells synthesize basie fibroblast growth factor. Release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90:2362-2369, 1992
80. NABEL EG, YANG Z, PLAUTZ G, FOROUGH R, ZHAN X, HAUDENSCHILD CC, MACIAG T, NABEL GJ: Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature 362:844-866, 1993
81. RIFKIN DB, MOSCATELLI D: Recent development in cell biology of basic fibroblast growth factor. J Cell Biol 109:1-7, 1989
82. GESUALDO L, DI PAOLO S, CALABRÒ A, MILAM S, MAIORANO E, RANIERI E, PANNARALE G, SCHENA FP: Expression of epidermal growth factor and its receptor in normal and diseased human kidney: An immunohistochemistry and in situ hybridization study. Kidney Int 49:656-665, 1996
83. FISHER DA, SALIDO EC, BARAJAS L: Epidermal growth factor and the kidney. Annu Rev Physiol 51:67-80, 1989
84. INTERNATIONAL STUDY OF KIDNEY DISEASE CHILDREN: Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159-165, 1978
85. INTERNATIONAL STUDY OF KIDNEY DISEASE CHILDREN: Early idetification of frequent relapses among children with minimal change nephrotic syndrome. J Pedriatr 101:514-518, 1982
86. SHARPSTONE P, OGG CS, CAMERON JS: Nephrotic syndrome due to primary renal disease in adults: A survey of incidence in South East England. Br Med J 2:533-535, 1969
87. WARDLE EN: Minimal change nephrosis and allergy. Nephron 74: 422-423, 1996
88. GOODE NP, SHIRES M, CRELLIN DM, APARICIO SR, DAVISON AM: Detection of glomerular anionic sites in post-embedded ultrathin sections using cationic colloidal gold. J Histochem Cytochem 39:965-972, 1991
89. GOODE NP, SHIRES M, APARICIO SR, DAVISON AM: Cationic colloidal gold-A novel marker for the demonstration of polyanion status in routine renal biopsies. Nephrol Dial Transplant 6:923-930, 1991
90. GROGGEL GC, STEVENSON J, HOVINGH P, LINKER A, BORDER WA: Changes in heparin sulfate correlate with increased glomerular permeability. Kidney Int 33:517-523, 1988
91. SAXENA S, ANDAL A, SHARMA S, CHANDRA M, SAXENA HMK: Immune status of children suffering from minimal change nephrotic syndrome. Indian J Pathol Microbiol 35:171-179, 1992
92. STACHOWSKI J, MICHALKIEWICZ J, LEWANDOWSKA-STACHOWIAK M, KTYNICKI T, JARMOLINSKI T, MACIE JE, WSKI J: Disorders of Th-1 and Th-2 lymphocyte balance in children with primary nephrotic syndrome. (abstract) Nephrol Dial Transplant 10:929, 1995
93. NEUHAUS TJ, WADWA M, CALLARD R, BARRATT TM: Increased IL-2, IL-4 and interferon-gamma in steroid sensitive nephrotic syndrome. Clin Exp Immunol 100:475-479, 1995
94. BAKKER WW, BALLER JFW, VAN LUYK WHJ, VAN DER HEM GK: Mononuclear blood cells from patients with minimal change nephrotic syndrome induce increased glomerular permeability in the rat kidney in vivo. Kidney Int 30:633-639, 1986
95. SHALOUB RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2:556-559, 1974
96. BOULTON JONES JM, TULLOCH I, DORE B, MCLAY A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 20:72-77, 1983
97. LAGRUE G, XHEMAUMONT S, BRANELLEC A, HIRBEC G, WEIL BB: A vascular permeability factor elaborated from lymphocytes. Demonstration in patients with nephrotic syndrome. Biomedicine 23:37-49, 1975
98. TOMIZAWA S, MARUYAMA K, NAGASAWA N, SUZUKI S, KUROUME T: Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome. Nephron 41:157-160, 1985
99. KOYAMA A, FUJISAKI M, KOBAYASHI M, IGARASHI TN, NARITA MA: Glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-660, 1991
100. SAXENA S, MITTAL A, ANDAL A: Pattern of interleukins in minimal change nephrotic syndrome of childhood. Nephron 65:56-61, 1993
101. LAGRUE G, PECH MA, BRANCELLEC AI, HESLAN JM, ROSTOKER G, SENIK A, LANG P: Increased interleukin-2 levels in lymphocyte culture supernatants from patients with idiopathic nephrotic syndrome, in Progress in Basement Membrane Research: Renal and Related Aspects in Health and Disease, edited by GUBLER MC, STIRNBER M, London, Libbey, 1988, pp 281-284
102. GARIN EH, BLANCHARD DK, MATSUSHIMA K, DJEU JY: IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45:1311-1317, 1994
103. BRICIO T, MOLINA A, EGIDO J, GONZALES E, MAMPASO F: IL-1 production in adriamycin-induced nephrotic syndrome in the rat. Clin Exp Immunol 87:117-124, 1992
104. HISANAGA S, KWASGOE H, YAMAMOTO Y, KUROKI N, FUJIMOTO S, TONAKA K, KUROKAWA M: Nephrotic syndrome associated with recombinant interleukin-2 therapy. Nephron 54:277-278, 1990
105. D'AGATI V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241, 1994
106. SAVIN VJ: Mechanisms of proteinuria in noninflammatory glomerular disease. Am J Kidney Dis 21:347-362, 1993
107. ARTERO M, BIAVA C, AMEND W, TOMLANOVICH S, VINCENTI F: Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 92:375-383, 1992
108. ARTERO ML, SHARMA R, SAVIN VJ, VINCENTI F: Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574-581, 1994
109. SENGGUTUVAN P, CAMERON JS, HARTLEY RB, RIGDEN S, CHANTLER C, HEYCOCK G, WILLIAMS DG, OGG C, KOFFMAN G: Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4:21-28, 1990
110. SAVIN VJ, SHARMA R, SHARMA M, MCCARTHY ET, SWAN SK, ELLIS E, LOVELL H, WARADY B, GUNWAR S, CHONKO AM, ARTERO M, VINCENTI F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883, 1996
111. SAVIN VJ, SHARMA R, LOVELL HB, WELLING DJ: Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3:1260-1269, 1992
112. DILEEPAN KN, SHARMA R, STECHSCHULTE D, SAVIN VJ: Effect of superoxide exposure on albumin permeability of isolated rat glomeruli. J Lab Clin Med 121:797-804, 1993
113. LI JZ, SHARMA R, DILEEPAN K, SAVIN VJ: Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int 46:1025-1030, 1994
114. SAVIN VJ, JOHNSON RJ, COUSER WG: C5b-9 increases albumin permeability of isolated rat glomeruli in vitro. Kidney Int 46:382-387, 1994
115. KERJASCHKI D: Dysfunction of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int 45:300-313, 1994
116. FUIANO G, COMI N, MAGRI P, SEPE V, BALLETTA MM, ESPOSITO C, UCCELLO F, DAL CANTON A, CONTE G: Serial morphometric analysis of sclerotic lesions in primary focal segmental glomerulosclerosis. J Am Soc Nephrol 7:49-55, 1996
117. STEIN-OAKLEY AN, MAGUIRE JA, DOWLING J, PERRY G, THOMSON NM: Altered expression of fibrogenic factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int 51:195-204, 1997
118. RAY PE, WEEKS B, BRUGGEMAN L, KOPP JB, OWENS J, BRYANT J, NOTKINS AL, KLOTMAN PE: Novel role of bFGF in the pathogenesis of AIDS-associated nephropathy in transgenic mice. (abstract) J Am Soc Nephrol 3:318, 1992
119. KOPP JB, MCCUME BK, NOTKIUS AL, SPORN MB, KLOTMAN PE: Increased expression of transforming growth factor beta (TGF beta) in HIV transgenic mouse kidney. (abstract) J Am Soc Nephrol 3:600, 1992
120. BORDER W, YANAMOTO T, NOBLE N, GOLD L, NAST C, COHEN A: HIV-associated nephropathy is linked to TGF-β and matrix protein expression in human kidney. (abstract) J Am Soc Nephrol 4:675, 1993
121. HEYMANN W, HACKEL DB, HARWOOD S, WILSON SGF, HUNTER JLP: Production of nephrotic syndrome in rats by Freunds adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 100:660-664, 1959
122. SUGISAKI TJ, KLASSEN J, ANDRES GA, MILGROM FJ, MCCLUSKEY RT: Passive transfer of Heymann's nephritis with serum. Kidney Int 3:66-73, 1973
123. KERJASCHKI D, FARQUHAR MG: Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 157:667-686, 1983
124. KERJASCHKI D, MIETTINNEN A, FARQUHAR MG: Initial events in the formation of immune deposits in passive Heymann nephritis. J Exp Med 166:109-128, 1987
125. 2-macroglobulin receptor associated protein. Human homologue of a Heymann nephritis antigen. J Biol Chem 266:13364-13369, 1991
126. PIETROMONACO S, KERJASCHKI D, BINDER S, ULLRICH R, FARQUHAR MG: Molecular cloning and DNA-sequencing of pathogenic epitope of the Heymann nephritis antigen gp330. Proc Natl Acad Sci USA 87:1811-1811, 1990
127. ROLLINO C, ROCCATELLO D, GIACHINO O, BASOLO B, PICCOLI G: Hepatitis C virus infection and membranous glomerulonephritis. Nephron 59:319-320, 1981
128. KERJASCHKI D, SCHULZE M, BINDER S: Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143:546-552, 1989
129. SCHULZE M, DONADIO JV, PRUCHNO CJ, BAKER PJ, JOHNSON RJ, STAHL RAK, WATKINS S, MARTIN DC, WURZNER R, GOTZE O, COUSER WG: Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 40:533-538, 1991
130. COUSER WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1:13-29, 1990
131. BRENCHLEY PE, COUPES B, SHORT CD, O'DONOGHUE DJ, BALLARDIE FW, MALLIK NP: Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41:933-937, 1992
132. PRUCHNO CJ, BURNS MM, SCHULZE M: Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis. Am J Pathol 38:203-211, 1991
133. SCHÖNERMARK M, DEPPISH R, RIEDASCH G, ROTHER K, HÄNSCH GM: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 196:331-337, 1991
134. ADLER S, BAKER PJ, JOHNSON RJ, OCHI RF, PRITZL P, COUSER WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77:762-767, 1986
135. 558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90:3645-3649, 1993
136. HONKANEN E, TEPPO AM, MERI S, LEHTO T, GRONHAGEN-RISKA C: Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9:1553-1559, 1994
137. NEALE TJ, RÄUGER BM, MACAULAY H, DUNBAR PR, HASAN Q, BOURKE A, MURRAY-MCINTOSH RP, KITCHING AR: Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 146:1444-1454, 1995
138. LEHTO T, HONKANEN E, TEPPO AM, MERI S: Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 47:1403-1411, 1995
139. SHANKLAND SJ, PIPPIN J, PICHLER RH, GORDON KL, FRIEDMAN S, GOLD LI, JOHNSON RJ, COUSER WG: Differential expression of transforming growth factor-β isoforms and receptor in experimental membranous nephropathy. Kidney Int 50:116-124, 1996
140. JOHNSON RJ, GRETCH DR, YAMARE H, HART J, BACCHI CE, HARTWELL P, COUSER WG, COREY L, WENER MH, ALPERS CE: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J MeD 328:465-470, 1993
141. HARLÉ JR, DISDIER P, DUSSOL B, BOLLA G, CASANOVA P, WEILLER PJ: Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 341:904-910, 1993
142. RENNKE HG: Secondary membranoproliferative glomerulonephritis. Kidney Int 47:643-656, 1995
143. SOMA J, SAITO T, SEINO J, SATO H, OOTAKA T, YUSA A, ABE K: Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (VD1c/CD18) in membranoproliferative glomerulonephritis type I. Clin Exp Immunol 100:269-276, 1995
144. SOMA J, SAITO T, SATO H, OOTAKA T, SEINO J, FURUTA T, ABE K: Intraglomerular immune cell infiltration and C3 deposits in membranoproliferative glomerulonephritis type I: A serial biopsy study of 25 cases. Am J Kidney Dis 23:365-373, 1994
145. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209-215, 1990
146. ABUOUD HE, GRANDALIANO G, PINZANI M, PIERCE GF, JAFFER F: Mitogenic signals for platelet-derived growth factor isoforms in human mesangial cells. J Cell Physiol 158:140-150, 1994
147. ISAKA Y, IMAI E, KANEDA Y, WADA A, ARAI M, FUJIWARA Y, UEDA N, KAMADA T: Glomerulosclcrosis induced by intrarenal in vivo transfection with PDGF or TGF-β genes. J Clin Invest 92:2597-2601, 1993
148. GESUALDO L, PINZANI M, FLORIANO J, HASSAN MO, NAGY MU, SCHENA FP, EMANCIPATOR SN, ABBOUD HE: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
149. GESUALDO L, DI PAOLO S, MILANI S, PINZANI M, GRAPPONE C, RANIERI E, PANNARALE G, SCHENA FP: Expression of platelet-derived growth factor receptors in normal and diseased human kidney: An immunohistochemistry and in situ hybridization study. J Clin Invest 94:50-58, 1994
150. BALLARDIE FW, GORDON MT, SHARPE PT, DARVILLE AM, CHENG H: Intrarenal cytokine mRNA expression and location in normal and IgA nephropathy tissue: TGF-α, TGF-β, IGF-1, IL-4, IL-6. Nephrol Dial Transplant 9:1545-1552, 1994
151. RANIERI E, GESUALDO L, PETRARULO F, SCHENA FP: Urinary IL-6/EGF ratio: A useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int 50:1990-2001, 1996
152. OSAKA H, KONISHI K, NAKAZATO Y: Interleukin 4 expression in mesangioproliferative glomerulonephritis. Am J Kidney Dis 23:242-246, 1994
153. YAMAMOTO T, NOBLE NA, COHEN AM, BORDER W: Expression of transforming growth factor-β in human glomerular diseases. Kidney Int 49:461-469, 1996
154. GRANDALIANO G, GESUALDO L, RANIERI E, MONNO R, MONTINARO V, MARRA F, SCHENA FP: Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 7:906-913, 1996
155. TAM FWK, PUSEY CD: The role of T lymphocytes in extracapillary glomerulonephritis. J Nephrol 8:305-316, 1995
156. HUANG X-R, TIPPING PG, SHUO L, HOLDSWORTH SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51:94-103, 1997
157. BOLTON WK, INNES JDJ, STURGILL BC, KAISER DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations. Kidney Int 32:869-876, 1987
158. NOLASCO FEB, CAMERON JS, HARTLEY B, COELHO A, HILDRETH G, REUBEN R: Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31:1160-1166, 1987
159. NEALE TJ, TIPPING PG, CARSON SD, HOEDSWORTH SR: Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 2:421-424, 1988
160. LI HI, HANCOCK WW, DOWLING JP, ATKINS RC: Activated (IL2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 39:793-798, 1991
161. ROVIN BD, RUMANCIK M, TAN L, DICKERSON J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71:536-542, 1994
162. WADA T, YOKOYAMA H, TOMOSUGI N, HISADA Y, OHTA S, NAITO T, KOBAYASHI K, MUKAIDA N, MATSUSHIMA K: Detection of urinary IL-8 in glomerular diseases. Kidney Int 46:455-460, 1994
163. WADA T, TOMOSUGI N, NAITO T, YOKOYAMA H, KOBAYASHI K, MUKAIDA N, MATSUSHIMA K: Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental immune complex-induced glomerulonephritis. J Exp Med 180:1135-1141, 1994
164. WADA T, YOKOYAMA H, FURUICHI K, KOBAYASHI K, HARADA K, NARUTO M, SU SB, AKIYAMA M, MUKAIDA N, MATSUSHIMA K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor. FASEB J 10:1418-1425, 1996
165. LAN HY, NIKOLIC-PATERSON DJ, ZARAMA M, VANNICE JL, ATKINS RC: Suppression of experimental crescentic glomerulonephritis by the IL-1 receptor antagonist. Kidney Int 43:479-485, 1993
166. EL NAHAS AM: Glomerulosclerosis: Intrinsic and extrinsic pathways. Nephrol Dial Transplant 11:773-777, 1996
167. KRIZ W: Progressive renal failure-Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
168. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation. J Clin Invest 92:2952-2962, 1993
169. FLOEGE J, JOHNSON RJ, GORDON K, JOHNSON RJ: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-448, 1991
170. FLOEGE J, ALPERS CE, BURNS MW, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497, 1992
171. DAVIES M, MARTIN J, THOMAS GJ, LOVETT DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
172. LOVETT DH, JOHNSON RJ, MARTI J, DAVIES M, COUSER WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98, 1992
173. BERGIJK EC, HEER ED, HOEDEMAEKER LEIDEN PJB: A reappraisal of immune-mediated glomerulosclerosis. Kidney Int 49:605-611, 1996
174. GUIJARRO C, KEANE WF: Lipid-induced glomerular injury. Nephron 67:1-6, 1994
175. KIM Y-S, BHANDARI B, ABBOUD HE: Angiotensin II (AngII) stimulates monocyte chemoattractant protein-1 (MCP-1) expression in rat mesangial cells. (abstract) J Am Soc Nephrol 7:1737, 1996
176. KEANE WF, KASISKE BL, O'DONNELI MP, KIM Y: Oxidized LDL increases mesangial cell expression of type IV collagen messenger RNA. J Am Soc Nephrol 3:635-371, 1992
177. NATH KA: Tubulointerstitial disease as a major determinant of progressive renal injury. Am J Kidney Dis 20:1-17, 1992
178. LAN HY, NIKOLIC-PATERSON DJ, ATKINS RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40:425-433, 1991
179. RUBIN-KELLY VE, JEVNIKAR AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 2:13-26, 1991
180. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
181. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
182. PICHLER R, GIACHELLI CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
183. HEEGER P, WOLF G, MEYERS C, SUN MJ, O'FARRELL SC, KRENSKY AM, NEILSON EG: Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 41:220-225, 1992
184. SAVILL J, MOONEY A, HUGHES J: Apoptosis and renal scarring. Kidney Int 49(Suppl 54):S14-S17, 1996
185. OKADA H, STRUTZ F, DANOFF TM, NEILSON EG: Possible pathogenesis of renal fibrosis. Kidney Int 49(Suppl 54):S37-S38, 1996
186. ALPERS CE, PICLER R, JOHNSON RJ: Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int 49(Suppl 54):S28-S31, 1996
187. TANG WW, ULICH TR, LACEY DL, HILL DC, QI M, KAUFMAN SA, VAN GY, TARPLEY JE, YEE JS: Plalelet-derived growth factor-BB induces renal tubulointerstitial myofibroblasts formation and tubulointerstitial fibrosis. Am J Pathol 148:1169-1180, 1996
188. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
189. PICHLER RH, HUGO C, REED M, ALPERS CE, ANDOH T, BASSUK J, LOMBARDI D, SCHWARTZ SM, SAGE EH, BENNETT WM, COUSER WG, JOHNSON RJ: SPARC is expressed in areas of tubulointerstitial and vascular injury in experimental models of renal disease. (abstract) J Am Soc Nephrol 6:907, 1995
190. LAN HY, NIKOLIC-PATERSON DJ, MU W, VANNICE JL, ATKINS RC: Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47:1303-1309, 1995
191. NIKOLIC-PATERSON DJ, LAN HY, HILL PA, VANNICE JL, ATKINS RC: Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: Inhibition of intercellular adhesion molecule-1 expression. J Am Soc Nephrol 4:1695-1700, 1994
192. TANG WW, FENG L, VANNICE JL, WILSON CB: IL-1 receptor antagonist ameliorates experimental anti-GBM antibody associated glomerulonephritis. J Clin Invest 93:273-279, 1994
193. GESUALDO L, DI PAOLO S, RANIERI E, SCHENA FP: Trapidil inhibits human mesangial cell proliferation: Effect on PDGF β receptor binding and expression. Kidney Int 46:1002-1009, 1994
194. FUTAMURA A, IIDA H, IZUMINO K, ENTANI C, TAKATA M: Effect of platelet-derived growth factor antagonist trapidil on rat mesangial cell proliferation. (abstract) J Am Soc Nephrol 3:588, 1992
195. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β. Nature 346:371-374, 1990
196. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
197. ISAKA Y, BREES DK, IKEGAYA K, KANEDA Y, IMAI E, NOBLE NA, BORDER WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 2:418-423, 1996
198. BRUGGE JS: New intracellular targets for therapeutic drug design. Science 260:918-919, 1993
199. IHLE BU, WHITWORTH JA, SHAHINFAR S, CANAAN A, KINCAID-SMITH PS, BECKER GJ: Angiotensin-converting enzyme inhibition in non diabetic progressive renal insufficiency: A controlleed double-blind trial. Am J Kidney Dis 27:489-495, 1996
200. MASCHIO G, ALBERTI D, JANON G, LOCATELLI F, MARN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P, ANGIOTENSIN CONVERTING ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
201. 2+ in glomerular mesangial cells. Kidney Int 46:696-702, 1994
202. KEANE WF, KASISKE BL, O'DONNELL MP, SCHMITZ PG: Therapeutic implication of lipid lowering agents in the progression of renal disease. Am J Med 87:21-24, 1989
203. GRANDALIANO G, BISWAS P, CHOUDHURY GG, ABBOUD HE: Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int 44:503-508, 1993
204. GUIJARRO C, KIM Y, SCHOONOVER CM, MASSY ZA, O'DONNELL MP, KASISKE BL, KEANE WF, KASHTAN CE: Lovastatin inhibits lipopolysaccharide-induced NF-κB activation in human mesangial cells. Nephrol Dial Transplant 11:990-996, 1996
205. SCHAFER WR, KIM R, STERNE R, THORNER J, KIM SH, RINE J: Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science 245:379-385, 1989
206. MUKAIDA N, ZACHARIAE CCO, GUSELLA GL, MATSUSHIMA K: Dexamethasone inhibits the induction of monocyte chemotactic activating factor production by IL-1 or tumor necrosis factor. J Immunol 146:1212-1218, 1991
207. WERTHEIM WA, KUNKEL SL, STANDIFIRD TJ: Regulation of neutrophil-derived IL-8: The rule of prostaglandin E2, dexamethasone and IL-4. J Immunol 151:2166-2172, 1991
208. MUKAIDA N, MORITA M, ISHIKAWA Y: Novel mechanism of glucocorticoid-mediated gene expression. J Biol Chem 269:13289-13295, 1994
209. LOETSCHER P, DEWALD B, BAGGIOLINI M, SEITZ M: monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes-Effects of anti-rheumatic drugs. Cytokine 6:162-171, 1994
210. BENNETT WM, DEMATTOS A, MEYER MM, ANDOH T, BARRY JM: Chronic cyclosporine nephropathy: The Achille's heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
211. ISHII H, JIROUSEK MR, KOYA D, TAKAGI C, XIA P, CLERMONT A, BURSEL SE, KERN TS, BALLAS LM, HEATH WF, STRAMM LE, FEENER EP, KING GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
212. STOBO JD, KENNEDY MD, GOLDYNE ME: Prostaglandin E modulation of mitogenic response of human T-cells. J Clin Invest 64:1188-1193, 1979
213. KUNKEL SL, ZANETTI M, SAPIN C: Suppression of nephrotoxic serum nephritis in rats by prostaglandin E1. Am J Pathol 108:240-245, 1982
214. JOCKS T, ZAHNER G, FREUDENBERG J, WOLF G, THAISS F, STAHL RAK: Prostaglandin E1 reduces the glomerular mRNA expression of monocyte chemotactic protein-1 in anti-thymocyte antibody-induced glomerular injury. J Am Soc Nephrol 7:897-905, 1996
215. PRUZANSKI W, VADAS P: Phospholipase A2-A mediator between proximal and distal effectors of inflammation. Immunol Today 12:143-146, 1991
216. 2-generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J Clin Invest 83:1936-1940, 1989
217. DANA R, MALECH HL, LEVY R: The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem J 297:217-223, 1994
218. HENDERSON LM, CHAPPELL JB, JONES OTG: Superoxide generation is inhibited by phospholipase A2 inhibitors. Role of phospholipase A2 in the activation of NADPH oxidase. Biochem J 264:249-255, 1989
219. CRYSTAL RG: The gene as the drug. Nature Med 1:15-17, 1995
220. KITAMURA M, BURTON S, ENGLISH J, KAWACHI H, FINE LG: Transfer of a mutated gene encoding active trasforming growth factor-β1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 48:1747-1757, 1995
221. MCCARTHY M: Reasons for optimism over vascular gene therapy. Lancet 347:9003, 1996
222. WAGNER RW: Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335, 1994
223. AKAGI Y, ISAKA Y, ARAI M, KANEKO T, MORIYAMA T, KANEDA Y, ANDO A, ORITA Y, KAMADA T, UEDA N, IMAI E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
224. WAGNER RW: The state of the art in antisense research. Nature Med 11:1116-1121, 1995
225. STEIN CA, CHENG YC: Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 261:1004-1012, 1993
226. MATTEUCCI MD, WAGNER RW: In pursuit of antisense. Nature 384:20-22, 1996
227. STEELE FR: Antisense patent trial wraps up. Nature Med 5:389, 1995
228. POWRIE F, COFFMAN RL: Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol Today 14:270-274, 1993
229. HALL SS: IL-12 at the crossroads. Science 268:1432-1434, 1995
230. THUS LG, HACK CE, STRACK VAN SCHIJNDEL RJM, NUIJENS JH, WOLBINK GJ, EERENBERG-BELMER AJM, VAN DEN VALL H, WACSTAFF J: Activation of the complement system during immunotherapy with recombinant IL-2. J Immunol 144:2419-2424, 1990
231. ROSEMBERG SA, LOTZE MT, MUUL LM, CHANG AE, AVIS FP, LEITMAN S, LINEHAM WM, ROBERTSON CM, LEE RE, RUBIN JT, SIEPP CA, SIMPSON CG, WHITE DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin 2 or interleukin 2 alone. N Engl J Med 316:889-895, 1987
232. KARKAR AM, TAM FWK, PROUDFOOT AEI, MEAGER A, REES AJ: Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int 44:967-973, 1993
233. ROLLWAGEN FM, BAQAR S: Oral cytokine administration. Immunol Today 17:548-550, 1996
234. ARENZANA-SEISDEDOS F, VIRELIZIER JL, ROUSSET D: HIV blocked by chemokine antagonist. Nature 383:400, 1996
235. WAISMAN A, RUIZ PJ, HIRSCHBERG DL, GELMAN A, OKSENBERG JR, BROCKE S, MOR F, COHEN IR, STEINMAN L: Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med 2:899-905, 1996
236. STÜNKEL KGE, HEWLETT G, ZEILER HJ: Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin Exp Immunol 86:525-531, 1994
237. KAGAMI S, BORDER WA, MILLER DA, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
238. RUIZ-ORTEGA M, GONZALES S, JERON D, CONDOM E, BUSTOS C, LARGO R, GONZALES E, ORTIZ A, EGIDO J: ACE-inhibition reduces proteinuria, glomerular lesion and extracellular matrix production in a normotensive rat model of immune-complex nephritis. Kidney Int 48:1778-1791, 1995
239. RUILOPE LM, MIRANDA B, MORALES JM, RODICIO JL, ROMERO JC, RAIJ L: Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 13:120-126, 1989
240. GANSEVOORT RT, SLUITER WJ, HEMMELDER MH, DE ZEEUW, DE JONG DE: Antiproteinuric effect of blood-pressure-lowering: A metanalysis of comparative trials. Nephrol Dial Transpl 10:1963-1974, 1995
241. PERICO N, AMUCHASTEGUI SC, COLOSIO V, SONZONI G, BERTANI T, REMUZZI G: Evidence that an angiotensin-converting-enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at wich the treatment is started. J Am Soc Nephrol 5:1139-1146, 1994
242. WARDLE EN: Heparins for proliferative nephritides? Short review on an advancing topic. Nephron 73:515-519, 1996
243. ZUGMAIER G, LIPPMAN ME, WELLSTEIN A: Inhibition by pentosan polysulphate of heparin binding growth factor released from tumor cells. J Natl Cancer Inst 84:1716-1724, 1992
244. RIX DA, DOUGLAS MS, TALBOT D, DARK JH, KIRBY JA: Role of glycosaminoglycans in regulation of the immunogenecity of human vascular endothelial cells. Clin Exp Immunol 104:60-65, 1996
245. OKUDA S, NAKAMURA T, YAMAMOTO T, RUOSLAHTI E, BORDER WA: Dietary protein restriction rapidly reduces transforming growth factor β expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 88:9765-9769, 1991
246. MADORE F, LAZARUS JM, BRADY HR: Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7:367-386, 1996
247. COUSER WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms and therapy. Am J Kindey Dis 11:449-464, 1988
248. LEWIS EJ, HUNSICKER LG, LAN S-P, ROHDE RD, LACHIN JM: A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373-1379, 1992
249. HAKIM RH, SIAMI A: Plasmapheresis, in Handbook of Dialysis, edited by DAUGIRDAS JT, ING T, Boston, Little, Brown and Co., 1994, pp 219-241